nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000788	0.000788	CcSEcCtD
Cefpodoxime—Insomnia—Mycophenolic acid—systemic scleroderma	0.000788	0.000788	CcSEcCtD
Cefpodoxime—Fatigue—Leflunomide—systemic scleroderma	0.000787	0.000787	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000785	0.000785	CcSEcCtD
Cefpodoxime—Pruritus—Captopril—systemic scleroderma	0.000784	0.000784	CcSEcCtD
Cefpodoxime—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000782	0.000782	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000782	0.000782	CcSEcCtD
Cefpodoxime—Constipation—Leflunomide—systemic scleroderma	0.000781	0.000781	CcSEcCtD
Cefpodoxime—Pain—Leflunomide—systemic scleroderma	0.000781	0.000781	CcSEcCtD
Cefpodoxime—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000779	0.000779	CcSEcCtD
Cefpodoxime—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000777	0.000777	CcSEcCtD
Cefpodoxime—Somnolence—Mycophenolic acid—systemic scleroderma	0.000774	0.000774	CcSEcCtD
Cefpodoxime—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000774	0.000774	CcSEcCtD
Cefpodoxime—Shock—Lisinopril—systemic scleroderma	0.000772	0.000772	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000768	0.000768	CcSEcCtD
Cefpodoxime—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000767	0.000767	CcSEcCtD
Cefpodoxime—Neutropenia—Prednisone—systemic scleroderma	0.000766	0.000766	CcSEcCtD
Cefpodoxime—Abdominal pain—Azathioprine—systemic scleroderma	0.000764	0.000764	CcSEcCtD
Cefpodoxime—Body temperature increased—Azathioprine—systemic scleroderma	0.000764	0.000764	CcSEcCtD
Cefpodoxime—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00076	0.00076	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000759	0.000759	CcSEcCtD
Cefpodoxime—Diarrhoea—Captopril—systemic scleroderma	0.000758	0.000758	CcSEcCtD
Cefpodoxime—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000757	0.000757	CcSEcCtD
Cefpodoxime—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000757	0.000757	CcSEcCtD
Cefpodoxime—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000755	0.000755	CcSEcCtD
Cefpodoxime—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000754	0.000754	CcSEcCtD
Cefpodoxime—Feeling abnormal—Leflunomide—systemic scleroderma	0.000753	0.000753	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000752	0.000752	CcSEcCtD
Cefpodoxime—Fatigue—Mycophenolic acid—systemic scleroderma	0.000751	0.000751	CcSEcCtD
Cefpodoxime—Nausea—Mometasone—systemic scleroderma	0.000749	0.000749	CcSEcCtD
Cefpodoxime—Anorexia—Lisinopril—systemic scleroderma	0.000748	0.000748	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000747	0.000747	CcSEcCtD
Cefpodoxime—Weight increased—Prednisone—systemic scleroderma	0.000746	0.000746	CcSEcCtD
Cefpodoxime—Pain—Mycophenolic acid—systemic scleroderma	0.000745	0.000745	CcSEcCtD
Cefpodoxime—Constipation—Mycophenolic acid—systemic scleroderma	0.000745	0.000745	CcSEcCtD
Cefpodoxime—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000744	0.000744	CcSEcCtD
Cefpodoxime—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00074	0.00074	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Prednisone—systemic scleroderma	0.000739	0.000739	CcSEcCtD
Cefpodoxime—Cough—Mycophenolate mofetil—systemic scleroderma	0.000735	0.000735	CcSEcCtD
Cefpodoxime—Hypotension—Lisinopril—systemic scleroderma	0.000733	0.000733	CcSEcCtD
Cefpodoxime—Dizziness—Captopril—systemic scleroderma	0.000733	0.000733	CcSEcCtD
Cefpodoxime—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00073	0.00073	CcSEcCtD
Cefpodoxime—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000727	0.000727	CcSEcCtD
Cefpodoxime—Urticaria—Leflunomide—systemic scleroderma	0.000725	0.000725	CcSEcCtD
Cefpodoxime—Body temperature increased—Leflunomide—systemic scleroderma	0.000722	0.000722	CcSEcCtD
Cefpodoxime—Abdominal pain—Leflunomide—systemic scleroderma	0.000722	0.000722	CcSEcCtD
Cefpodoxime—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000718	0.000718	CcSEcCtD
Cefpodoxime—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000717	0.000717	CcSEcCtD
Cefpodoxime—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000717	0.000717	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000715	0.000715	CcSEcCtD
Cefpodoxime—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000715	0.000715	CcSEcCtD
Cefpodoxime—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000714	0.000714	CcSEcCtD
Cefpodoxime—Hypersensitivity—Azathioprine—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000712	0.000712	CcSEcCtD
Cefpodoxime—Insomnia—Lisinopril—systemic scleroderma	0.00071	0.00071	CcSEcCtD
Cefpodoxime—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000709	0.000709	CcSEcCtD
Cefpodoxime—Paraesthesia—Lisinopril—systemic scleroderma	0.000705	0.000705	CcSEcCtD
Cefpodoxime—Vomiting—Captopril—systemic scleroderma	0.000704	0.000704	CcSEcCtD
Cefpodoxime—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000701	0.000701	CcSEcCtD
Cefpodoxime—Dyspnoea—Lisinopril—systemic scleroderma	0.0007	0.0007	CcSEcCtD
Cefpodoxime—Rash—Captopril—systemic scleroderma	0.000699	0.000699	CcSEcCtD
Cefpodoxime—Dermatitis—Captopril—systemic scleroderma	0.000698	0.000698	CcSEcCtD
Cefpodoxime—Somnolence—Lisinopril—systemic scleroderma	0.000698	0.000698	CcSEcCtD
Cefpodoxime—Headache—Captopril—systemic scleroderma	0.000694	0.000694	CcSEcCtD
Cefpodoxime—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000693	0.000693	CcSEcCtD
Cefpodoxime—Dyspepsia—Lisinopril—systemic scleroderma	0.000691	0.000691	CcSEcCtD
Cefpodoxime—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000689	0.000689	CcSEcCtD
Cefpodoxime—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000689	0.000689	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000688	0.000688	CcSEcCtD
Cefpodoxime—Asthma—Methotrexate—systemic scleroderma	0.000685	0.000685	CcSEcCtD
Cefpodoxime—Decreased appetite—Lisinopril—systemic scleroderma	0.000682	0.000682	CcSEcCtD
Cefpodoxime—Eosinophilia—Methotrexate—systemic scleroderma	0.000678	0.000678	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Cefpodoxime—Fatigue—Lisinopril—systemic scleroderma	0.000677	0.000677	CcSEcCtD
Cefpodoxime—Shock—Mycophenolate mofetil—systemic scleroderma	0.000676	0.000676	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000673	0.000673	CcSEcCtD
Cefpodoxime—Hypersensitivity—Leflunomide—systemic scleroderma	0.000673	0.000673	CcSEcCtD
Cefpodoxime—Pain—Lisinopril—systemic scleroderma	0.000671	0.000671	CcSEcCtD
Cefpodoxime—Constipation—Lisinopril—systemic scleroderma	0.000671	0.000671	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000665	0.000665	CcSEcCtD
Cefpodoxime—Diarrhoea—Azathioprine—systemic scleroderma	0.000662	0.000662	CcSEcCtD
Cefpodoxime—Haemoglobin—Prednisone—systemic scleroderma	0.000659	0.000659	CcSEcCtD
Cefpodoxime—Nausea—Captopril—systemic scleroderma	0.000658	0.000658	CcSEcCtD
Cefpodoxime—Haemorrhage—Prednisone—systemic scleroderma	0.000656	0.000656	CcSEcCtD
Cefpodoxime—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000655	0.000655	CcSEcCtD
Cefpodoxime—Asthenia—Leflunomide—systemic scleroderma	0.000655	0.000655	CcSEcCtD
Cefpodoxime—Hallucination—Prednisone—systemic scleroderma	0.000653	0.000653	CcSEcCtD
Cefpodoxime—Pancytopenia—Methotrexate—systemic scleroderma	0.00065	0.00065	CcSEcCtD
Cefpodoxime—Feeling abnormal—Lisinopril—systemic scleroderma	0.000647	0.000647	CcSEcCtD
Cefpodoxime—Pruritus—Leflunomide—systemic scleroderma	0.000646	0.000646	CcSEcCtD
Cefpodoxime—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000642	0.000642	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000642	0.000642	CcSEcCtD
Cefpodoxime—Neutropenia—Methotrexate—systemic scleroderma	0.00064	0.00064	CcSEcCtD
Cefpodoxime—Dysuria—Methotrexate—systemic scleroderma	0.00064	0.00064	CcSEcCtD
Cefpodoxime—Dizziness—Azathioprine—systemic scleroderma	0.000639	0.000639	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000626	0.000626	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000625	0.000625	CcSEcCtD
Cefpodoxime—Asthenia—Mycophenolic acid—systemic scleroderma	0.000625	0.000625	CcSEcCtD
Cefpodoxime—Diarrhoea—Leflunomide—systemic scleroderma	0.000625	0.000625	CcSEcCtD
Cefpodoxime—Urticaria—Lisinopril—systemic scleroderma	0.000623	0.000623	CcSEcCtD
Cefpodoxime—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000622	0.000622	CcSEcCtD
Cefpodoxime—Abdominal pain—Lisinopril—systemic scleroderma	0.00062	0.00062	CcSEcCtD
Cefpodoxime—Body temperature increased—Lisinopril—systemic scleroderma	0.00062	0.00062	CcSEcCtD
Cefpodoxime—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000617	0.000617	CcSEcCtD
Cefpodoxime—Pruritus—Mycophenolic acid—systemic scleroderma	0.000616	0.000616	CcSEcCtD
Cefpodoxime—Vomiting—Azathioprine—systemic scleroderma	0.000615	0.000615	CcSEcCtD
Cefpodoxime—Pneumonia—Methotrexate—systemic scleroderma	0.000614	0.000614	CcSEcCtD
Cefpodoxime—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000613	0.000613	CcSEcCtD
Cefpodoxime—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000611	0.000611	CcSEcCtD
Cefpodoxime—Rash—Azathioprine—systemic scleroderma	0.00061	0.00061	CcSEcCtD
Cefpodoxime—Dermatitis—Azathioprine—systemic scleroderma	0.000609	0.000609	CcSEcCtD
Cefpodoxime—Headache—Azathioprine—systemic scleroderma	0.000606	0.000606	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000605	0.000605	CcSEcCtD
Cefpodoxime—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000605	0.000605	CcSEcCtD
Cefpodoxime—Dizziness—Leflunomide—systemic scleroderma	0.000604	0.000604	CcSEcCtD
Cefpodoxime—Renal failure—Methotrexate—systemic scleroderma	0.0006	0.0006	CcSEcCtD
Cefpodoxime—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000598	0.000598	CcSEcCtD
Cefpodoxime—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000596	0.000596	CcSEcCtD
Cefpodoxime—Stomatitis—Methotrexate—systemic scleroderma	0.000595	0.000595	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000594	0.000594	CcSEcCtD
Cefpodoxime—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000588	0.000588	CcSEcCtD
Cefpodoxime—Pain—Mycophenolate mofetil—systemic scleroderma	0.000588	0.000588	CcSEcCtD
Cefpodoxime—Haematuria—Methotrexate—systemic scleroderma	0.000582	0.000582	CcSEcCtD
Cefpodoxime—Vomiting—Leflunomide—systemic scleroderma	0.000581	0.000581	CcSEcCtD
Cefpodoxime—Alopecia—Prednisone—systemic scleroderma	0.00058	0.00058	CcSEcCtD
Cefpodoxime—Hypersensitivity—Lisinopril—systemic scleroderma	0.000578	0.000578	CcSEcCtD
Cefpodoxime—Dizziness—Mycophenolic acid—systemic scleroderma	0.000576	0.000576	CcSEcCtD
Cefpodoxime—Epistaxis—Methotrexate—systemic scleroderma	0.000576	0.000576	CcSEcCtD
Cefpodoxime—Rash—Leflunomide—systemic scleroderma	0.000576	0.000576	CcSEcCtD
Cefpodoxime—Dermatitis—Leflunomide—systemic scleroderma	0.000575	0.000575	CcSEcCtD
Cefpodoxime—Nausea—Azathioprine—systemic scleroderma	0.000574	0.000574	CcSEcCtD
Cefpodoxime—Headache—Leflunomide—systemic scleroderma	0.000572	0.000572	CcSEcCtD
Cefpodoxime—Agranulocytosis—Methotrexate—systemic scleroderma	0.00057	0.00057	CcSEcCtD
Cefpodoxime—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000567	0.000567	CcSEcCtD
Cefpodoxime—Asthenia—Lisinopril—systemic scleroderma	0.000563	0.000563	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000562	0.000562	CcSEcCtD
Cefpodoxime—Pruritus—Lisinopril—systemic scleroderma	0.000555	0.000555	CcSEcCtD
Cefpodoxime—Vomiting—Mycophenolic acid—systemic scleroderma	0.000554	0.000554	CcSEcCtD
Cefpodoxime—Haemoglobin—Methotrexate—systemic scleroderma	0.000551	0.000551	CcSEcCtD
Cefpodoxime—Rash—Mycophenolic acid—systemic scleroderma	0.000549	0.000549	CcSEcCtD
Cefpodoxime—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000549	0.000549	CcSEcCtD
Cefpodoxime—Haemorrhage—Methotrexate—systemic scleroderma	0.000548	0.000548	CcSEcCtD
Cefpodoxime—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000546	0.000546	CcSEcCtD
Cefpodoxime—Headache—Mycophenolic acid—systemic scleroderma	0.000546	0.000546	CcSEcCtD
Cefpodoxime—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000543	0.000543	CcSEcCtD
Cefpodoxime—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000543	0.000543	CcSEcCtD
Cefpodoxime—Nausea—Leflunomide—systemic scleroderma	0.000542	0.000542	CcSEcCtD
Cefpodoxime—Diarrhoea—Lisinopril—systemic scleroderma	0.000537	0.000537	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Prednisone—systemic scleroderma	0.00053	0.00053	CcSEcCtD
Cefpodoxime—Anaemia—Prednisone—systemic scleroderma	0.000528	0.000528	CcSEcCtD
Cefpodoxime—Agitation—Prednisone—systemic scleroderma	0.000525	0.000525	CcSEcCtD
Cefpodoxime—Dizziness—Lisinopril—systemic scleroderma	0.000519	0.000519	CcSEcCtD
Cefpodoxime—Erythema multiforme—Methotrexate—systemic scleroderma	0.000518	0.000518	CcSEcCtD
Cefpodoxime—Nausea—Mycophenolic acid—systemic scleroderma	0.000517	0.000517	CcSEcCtD
Cefpodoxime—Malaise—Prednisone—systemic scleroderma	0.000515	0.000515	CcSEcCtD
Cefpodoxime—Vertigo—Prednisone—systemic scleroderma	0.000513	0.000513	CcSEcCtD
Cefpodoxime—Syncope—Prednisone—systemic scleroderma	0.000512	0.000512	CcSEcCtD
Cefpodoxime—Tinnitus—Methotrexate—systemic scleroderma	0.000511	0.000511	CcSEcCtD
Cefpodoxime—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000507	0.000507	CcSEcCtD
Cefpodoxime—Loss of consciousness—Prednisone—systemic scleroderma	0.000502	0.000502	CcSEcCtD
Cefpodoxime—Vomiting—Lisinopril—systemic scleroderma	0.000499	0.000499	CcSEcCtD
Cefpodoxime—Rash—Lisinopril—systemic scleroderma	0.000495	0.000495	CcSEcCtD
Cefpodoxime—Convulsion—Prednisone—systemic scleroderma	0.000495	0.000495	CcSEcCtD
Cefpodoxime—Dermatitis—Lisinopril—systemic scleroderma	0.000494	0.000494	CcSEcCtD
Cefpodoxime—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000493	0.000493	CcSEcCtD
Cefpodoxime—Hypertension—Prednisone—systemic scleroderma	0.000493	0.000493	CcSEcCtD
Cefpodoxime—Chills—Methotrexate—systemic scleroderma	0.000492	0.000492	CcSEcCtD
Cefpodoxime—Headache—Lisinopril—systemic scleroderma	0.000492	0.000492	CcSEcCtD
Cefpodoxime—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000486	0.000486	CcSEcCtD
Cefpodoxime—Myalgia—Prednisone—systemic scleroderma	0.000486	0.000486	CcSEcCtD
Cefpodoxime—Anxiety—Prednisone—systemic scleroderma	0.000484	0.000484	CcSEcCtD
Cefpodoxime—Alopecia—Methotrexate—systemic scleroderma	0.000484	0.000484	CcSEcCtD
Cefpodoxime—Discomfort—Prednisone—systemic scleroderma	0.00048	0.00048	CcSEcCtD
Cefpodoxime—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00047	0.00047	CcSEcCtD
Cefpodoxime—Dysgeusia—Methotrexate—systemic scleroderma	0.000467	0.000467	CcSEcCtD
Cefpodoxime—Nausea—Lisinopril—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Prednisone—systemic scleroderma	0.000466	0.000466	CcSEcCtD
Cefpodoxime—Back pain—Methotrexate—systemic scleroderma	0.000462	0.000462	CcSEcCtD
Cefpodoxime—Shock—Prednisone—systemic scleroderma	0.000458	0.000458	CcSEcCtD
Cefpodoxime—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000455	0.000455	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Prednisone—systemic scleroderma	0.000451	0.000451	CcSEcCtD
Cefpodoxime—Anorexia—Prednisone—systemic scleroderma	0.000444	0.000444	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000443	0.000443	CcSEcCtD
Cefpodoxime—Anaemia—Methotrexate—systemic scleroderma	0.000441	0.000441	CcSEcCtD
Cefpodoxime—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000437	0.000437	CcSEcCtD
Cefpodoxime—Rash—Mycophenolate mofetil—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Cefpodoxime—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000433	0.000433	CcSEcCtD
Cefpodoxime—Headache—Mycophenolate mofetil—systemic scleroderma	0.000431	0.000431	CcSEcCtD
Cefpodoxime—Malaise—Methotrexate—systemic scleroderma	0.00043	0.00043	CcSEcCtD
Cefpodoxime—Vertigo—Methotrexate—systemic scleroderma	0.000429	0.000429	CcSEcCtD
Cefpodoxime—Leukopenia—Methotrexate—systemic scleroderma	0.000427	0.000427	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000425	0.000425	CcSEcCtD
Cefpodoxime—Insomnia—Prednisone—systemic scleroderma	0.000422	0.000422	CcSEcCtD
Cefpodoxime—Paraesthesia—Prednisone—systemic scleroderma	0.000418	0.000418	CcSEcCtD
Cefpodoxime—Cough—Methotrexate—systemic scleroderma	0.000416	0.000416	CcSEcCtD
Cefpodoxime—Convulsion—Methotrexate—systemic scleroderma	0.000413	0.000413	CcSEcCtD
Cefpodoxime—Dyspepsia—Prednisone—systemic scleroderma	0.00041	0.00041	CcSEcCtD
Cefpodoxime—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000408	0.000408	CcSEcCtD
Cefpodoxime—Chest pain—Methotrexate—systemic scleroderma	0.000406	0.000406	CcSEcCtD
Cefpodoxime—Myalgia—Methotrexate—systemic scleroderma	0.000406	0.000406	CcSEcCtD
Cefpodoxime—Decreased appetite—Prednisone—systemic scleroderma	0.000405	0.000405	CcSEcCtD
Cefpodoxime—Fatigue—Prednisone—systemic scleroderma	0.000402	0.000402	CcSEcCtD
Cefpodoxime—Discomfort—Methotrexate—systemic scleroderma	0.000401	0.000401	CcSEcCtD
Cefpodoxime—Constipation—Prednisone—systemic scleroderma	0.000399	0.000399	CcSEcCtD
Cefpodoxime—Confusional state—Methotrexate—systemic scleroderma	0.000393	0.000393	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000389	0.000389	CcSEcCtD
Cefpodoxime—Feeling abnormal—Prednisone—systemic scleroderma	0.000384	0.000384	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000381	0.000381	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000381	0.000381	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000377	0.000377	CcSEcCtD
Cefpodoxime—Anorexia—Methotrexate—systemic scleroderma	0.000371	0.000371	CcSEcCtD
Cefpodoxime—Urticaria—Prednisone—systemic scleroderma	0.00037	0.00037	CcSEcCtD
Cefpodoxime—Abdominal pain—Prednisone—systemic scleroderma	0.000368	0.000368	CcSEcCtD
Cefpodoxime—Body temperature increased—Prednisone—systemic scleroderma	0.000368	0.000368	CcSEcCtD
Cefpodoxime—Hypotension—Methotrexate—systemic scleroderma	0.000364	0.000364	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000355	0.000355	CcSEcCtD
Cefpodoxime—Insomnia—Methotrexate—systemic scleroderma	0.000352	0.000352	CcSEcCtD
Cefpodoxime—Paraesthesia—Methotrexate—systemic scleroderma	0.00035	0.00035	CcSEcCtD
Cefpodoxime—Dyspnoea—Methotrexate—systemic scleroderma	0.000347	0.000347	CcSEcCtD
Cefpodoxime—Somnolence—Methotrexate—systemic scleroderma	0.000346	0.000346	CcSEcCtD
Cefpodoxime—Hypersensitivity—Prednisone—systemic scleroderma	0.000343	0.000343	CcSEcCtD
Cefpodoxime—Dyspepsia—Methotrexate—systemic scleroderma	0.000343	0.000343	CcSEcCtD
Cefpodoxime—Decreased appetite—Methotrexate—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000336	0.000336	CcSEcCtD
Cefpodoxime—Fatigue—Methotrexate—systemic scleroderma	0.000336	0.000336	CcSEcCtD
Cefpodoxime—Asthenia—Prednisone—systemic scleroderma	0.000334	0.000334	CcSEcCtD
Cefpodoxime—Pain—Methotrexate—systemic scleroderma	0.000333	0.000333	CcSEcCtD
Cefpodoxime—Pruritus—Prednisone—systemic scleroderma	0.00033	0.00033	CcSEcCtD
Cefpodoxime—Feeling abnormal—Methotrexate—systemic scleroderma	0.000321	0.000321	CcSEcCtD
Cefpodoxime—Diarrhoea—Prednisone—systemic scleroderma	0.000319	0.000319	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Cefpodoxime—Urticaria—Methotrexate—systemic scleroderma	0.000309	0.000309	CcSEcCtD
Cefpodoxime—Dizziness—Prednisone—systemic scleroderma	0.000308	0.000308	CcSEcCtD
Cefpodoxime—Body temperature increased—Methotrexate—systemic scleroderma	0.000308	0.000308	CcSEcCtD
Cefpodoxime—Abdominal pain—Methotrexate—systemic scleroderma	0.000308	0.000308	CcSEcCtD
Cefpodoxime—Vomiting—Prednisone—systemic scleroderma	0.000296	0.000296	CcSEcCtD
Cefpodoxime—Rash—Prednisone—systemic scleroderma	0.000294	0.000294	CcSEcCtD
Cefpodoxime—Dermatitis—Prednisone—systemic scleroderma	0.000294	0.000294	CcSEcCtD
Cefpodoxime—Headache—Prednisone—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Cefpodoxime—Hypersensitivity—Methotrexate—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Cefpodoxime—Asthenia—Methotrexate—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Cefpodoxime—Nausea—Prednisone—systemic scleroderma	0.000277	0.000277	CcSEcCtD
Cefpodoxime—Pruritus—Methotrexate—systemic scleroderma	0.000276	0.000276	CcSEcCtD
Cefpodoxime—Diarrhoea—Methotrexate—systemic scleroderma	0.000266	0.000266	CcSEcCtD
Cefpodoxime—Dizziness—Methotrexate—systemic scleroderma	0.000258	0.000258	CcSEcCtD
Cefpodoxime—Vomiting—Methotrexate—systemic scleroderma	0.000248	0.000248	CcSEcCtD
Cefpodoxime—Rash—Methotrexate—systemic scleroderma	0.000246	0.000246	CcSEcCtD
Cefpodoxime—Dermatitis—Methotrexate—systemic scleroderma	0.000245	0.000245	CcSEcCtD
Cefpodoxime—Headache—Methotrexate—systemic scleroderma	0.000244	0.000244	CcSEcCtD
Cefpodoxime—Nausea—Methotrexate—systemic scleroderma	0.000231	0.000231	CcSEcCtD
